235 related articles for article (PubMed ID: 19474683)
1. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
[TBL] [Abstract][Full Text] [Related]
2. lymph node ratio as a prognostic factor in patients with stage III rectal cancer treated with total mesorectal excision followed by chemoradiotherapy.
Kim YS; Kim JH; Yoon SM; Choi EK; Ahn SD; Lee SW; Kim JC; Yu CS; Kim HC; Kim TW; Chang HM
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):796-802. PubMed ID: 19289261
[TBL] [Abstract][Full Text] [Related]
3. The prognostic impact of the number of lymph nodes retrieved after neoadjuvant chemoradiotherapy with mesorectal excision for rectal cancer.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH; Kim H; Keum KC; Ahn JB
J Surg Oncol; 2009 Jul; 100(1):1-7. PubMed ID: 19418495
[TBL] [Abstract][Full Text] [Related]
4. Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer.
Ha YH; Jeong SY; Lim SB; Choi HS; Hong YS; Chang HJ; Kim DY; Jung KH; Park JG
Ann Surg; 2010 Aug; 252(2):336-40. PubMed ID: 20647928
[TBL] [Abstract][Full Text] [Related]
5. Survival in stage III colon cancer is independent of the total number of lymph nodes retrieved.
Tsikitis VL; Larson DL; Wolff BG; Kennedy G; Diehl N; Qin R; Dozois EJ; Cima RR
J Am Coll Surg; 2009 Jan; 208(1):42-7. PubMed ID: 19228501
[TBL] [Abstract][Full Text] [Related]
6. Lymph nodes after preoperative chemoradiotherapy for rectal carcinoma: number, status, and impact on survival.
Rullier A; Laurent C; Capdepont M; Vendrely V; Belleannée G; Bioulac-Sage P; Rullier E
Am J Surg Pathol; 2008 Jan; 32(1):45-50. PubMed ID: 18162769
[TBL] [Abstract][Full Text] [Related]
7. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
8. Predictive factors affecting survival in stage II colorectal cancer: is lymph node harvesting relevant?
Peeples C; Shellnut J; Wasvary H; Riggs T; Sacksner J
Dis Colon Rectum; 2010 Nov; 53(11):1517-23. PubMed ID: 20940600
[TBL] [Abstract][Full Text] [Related]
9. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer.
Sarli L; Bader G; Iusco D; Salvemini C; Mauro DD; Mazzeo A; Regina G; Roncoroni L
Eur J Cancer; 2005 Jan; 41(2):272-9. PubMed ID: 15661553
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors affecting local recurrence and survival for operable rectal cancers.
Kuru B; Camlibel M; Dinç S; Erdem E; Alagöl H
J Exp Clin Cancer Res; 2002 Sep; 21(3):329-35. PubMed ID: 12385573
[TBL] [Abstract][Full Text] [Related]
11. Is postoperative radiotherapy useful for the rectal carcinoma in the era of total mesorectal excision?
Suh KW; Kim BW; Chun M; Lim HY
Hepatogastroenterology; 2002; 49(44):399-403. PubMed ID: 11995460
[TBL] [Abstract][Full Text] [Related]
12. Metastasis to the sigmoid or sigmoid mesenteric lymph nodes from rectal cancer.
Park IJ; Choi GS; Lim KH; Kang BM; Jun SH
Ann Surg; 2009 Jun; 249(6):960-4. PubMed ID: 19474698
[TBL] [Abstract][Full Text] [Related]
13. What factors affect lymph node yield in surgery for rectal cancer?
Thorn CC; Woodcock NP; Scott N; Verbeke C; Scott SB; Ambrose NS
Colorectal Dis; 2004 Sep; 6(5):356-61. PubMed ID: 15335370
[TBL] [Abstract][Full Text] [Related]
14. Lateral lymph node dissection for lower rectal cancer.
Shiozawa M; Akaike M; Yamada R; Godai T; Yamamoto N; Saito H; Sugimasa Y; Takemiya S; Rino Y; Imada T
Hepatogastroenterology; 2007 Jun; 54(76):1066-70. PubMed ID: 17629040
[TBL] [Abstract][Full Text] [Related]
15. The surgeon as prognostic factor for local recurrence and survival in the anal sphincter preservation for mid-rectal cancer.
Luna-Pérez P; Reyna Huelga A; Labastida Almendaro S; Rodríguez-Coria DF; González Macouzet J; Delgado Gallardo S
Rev Invest Clin; 1999; 51(4):205-13. PubMed ID: 10546501
[TBL] [Abstract][Full Text] [Related]
16. Number and size of lymph nodes recovered from dukes B rectal cancers: correlation with prognosis and histologic antitumor immune response.
Murphy J; Pocard M; Jass JR; O'Sullivan GC; Lee G; Talbot IC
Dis Colon Rectum; 2007 Oct; 50(10):1526-34. PubMed ID: 17828403
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision with selective lateral pelvic lymphadenectomy: a multicenter randomized controlled trial.
Akasu T; Moriya Y; Ohashi Y; Yoshida S; Shirao K; Kodaira S;
Jpn J Clin Oncol; 2006 Apr; 36(4):237-44. PubMed ID: 16675478
[TBL] [Abstract][Full Text] [Related]
18. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined.
Cianchi F; Palomba A; Boddi V; Messerini L; Pucciani F; Perigli G; Bechi P; Cortesini C
World J Surg; 2002 Mar; 26(3):384-9. PubMed ID: 11865379
[TBL] [Abstract][Full Text] [Related]
19. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
20. Results of laparoscopic anterior resection for rectal adenocarcinoma: retrospective analysis of 157 cases.
Pugliese R; Di Lernia S; Sansonna F; Scandroglio I; Maggioni D; Ferrari GC; Costanzi A; Magistro C; De Carli S
Am J Surg; 2008 Feb; 195(2):233-8. PubMed ID: 18083137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
